Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FlutiForm vs Components in Mild to Moderate Asthma
NCT00393991Phase 3Completed
- Sponsor
- Skyepharma
- Start
- Jul 2006
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate and formoterol in asthma (4 arms), sponsored by Skyepharma. Primary endpoint: Change in Forced Expiratory Volume in 1 second at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
fluticasone propionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00393991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393991.